This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Ben Andrews, Ph.D.
Scientific Investigator at GlaxoSmithKline


Ben Andrews is a process chemist in Chemical Development at GlaxoSmithKline (Stevenage, UK). He has a background in organic chemistry with a PhD and postdoc in the field of asymmetric synthesis. In his 17 years at GSK he has contributed to the development of several mid to late phase compounds, from small molecules to oligonucleotides. He has 10 years’ experience of oligonucleotide manufacturing with expertise in synthesis, purification and isolation. He is a member of the European Pharma Oligonucleotide Consortium (EPOC) purge factor team, a co-lead of the ACS GCIPR oligonucleotide team and a GSK Fellow.

Agenda Sessions

  • ROOM 204AB: Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing